Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome

PURPOSE: A multicenter phase II study was conducted to assess the efficacy of rituximab, methotrexate, procarbazine, and vincristine (R-MPV) followed by consolidation reduced-dose whole-brain radiotherapy (rdWBRT) and cytarabine in primary CNS lymphoma. PATIENTS AND METHODS: Patients received induct...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Clin Oncol
Hauptverfasser: Morris, Patrick G., Correa, Denise D., Yahalom, Joachim, Raizer, Jeffrey J., Schiff, David, Grant, Barbara, Grimm, Sean, Lai, Rose K., Reiner, Anne S., Panageas, Kathy, Karimi, Sasan, Curry, Richard, Shah, Gaurav, Abrey, Lauren E., DeAngelis, Lisa M., Omuro, Antonio
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Clinical Oncology 2013
Schlagworte:
Original Reports
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5569679/
https://ncbi.nlm.nih.gov/pubmed/24101038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.50.4910
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge